Showing results (111-120 of 242) with videos related to
Sort By:
Pageof 25
Genome Research|August 18, 2012
A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylationChristopher G Duncan, Benjamin G Barwick, Genglin Jin, et al.Oncoimmunology|May 8, 2015
Novel role of hematopoietic stem cells in immunologic rejection of malignant gliomasCatherine Flores, Christina Pham, David Snyder, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiformeChris A Learn, Tristan L Hartzell, Carol J Wikstrand, et al.Cancer|August 24, 2005
Survival analysis of presumptive prognostic markers among oligodendrogliomasRoger E McLendon, James E Herndon, Bryan West, et al.Cancer Research|December 24, 2009
OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomasDavid C Adamson, Qun Shi, Matthew Wortham, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell functionPeter E Fecci, Hidenobu Ochiai, Duane A Mitchell, et al.Journal of Neuropathology and Experimental Neurology|December 1, 2018
MGMT: Immunohistochemical Detection in High-Grade AstrocytomasEric S Lipp, Patrick Healy, Alan Austin, et al.Expert Review of Anticancer Therapy|May 13, 2008
Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant gliomaRichard G Everson, Michael W Graner, Matthias Gromeier, et al.Cancer Research|August 4, 2004
Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomasDaniel K Broderick, Chunhui Di, Timothy J Parrett, et al.Proceedings of the National Academy of Sciences of the United States of America|December 19, 2012
Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral gliomaBryan D Choi, Chien-Tsun Kuan, Mingqing Cai, et al.Pageof 25